The asults of forty-twe pabents witll AMI(≥60 yeas 26 cases) treated with intravenous urokinasc(Group A) were reported. Another 168 patientswith AMI wthout urokinase administration in thesame period (Group B) were se...The asults of forty-twe pabents witll AMI(≥60 yeas 26 cases) treated with intravenous urokinasc(Group A) were reported. Another 168 patientswith AMI wthout urokinase administration in thesame period (Group B) were selectcd for compari-son. The coronary artery recanalization rate ofGroup A paticnts were 61.9% with no significantdifferencc between those aged ≤60 years and≥60 yeas (P>0.05). The hospitalization mor-tality was significantly lowcr in Group A (4.8%)than in Group B(22.6%, P<0.001). In paticntsaged ≥60 years, the hospitalization mortality wilssigniticantly lower in Grolip A (7.7%) than inGroup B too(27.1 %, P<0.01). Four Group A pa-tients complicateed with mild haemorrhage andtwo with hypotention. The effcctiveness and safetyor thrombolytic therapy in eldly patients withAMI were discussed.展开更多
文摘The asults of forty-twe pabents witll AMI(≥60 yeas 26 cases) treated with intravenous urokinasc(Group A) were reported. Another 168 patientswith AMI wthout urokinase administration in thesame period (Group B) were selectcd for compari-son. The coronary artery recanalization rate ofGroup A paticnts were 61.9% with no significantdifferencc between those aged ≤60 years and≥60 yeas (P>0.05). The hospitalization mor-tality was significantly lowcr in Group A (4.8%)than in Group B(22.6%, P<0.001). In paticntsaged ≥60 years, the hospitalization mortality wilssigniticantly lower in Grolip A (7.7%) than inGroup B too(27.1 %, P<0.01). Four Group A pa-tients complicateed with mild haemorrhage andtwo with hypotention. The effcctiveness and safetyor thrombolytic therapy in eldly patients withAMI were discussed.
